<DOC>
	<DOCNO>NCT00390884</DOCNO>
	<brief_summary>To compare group respect influenza immune response follow Dose 1 Fluzone vaccine ( 2006-2007 formulation ) .</brief_summary>
	<brief_title>Safety Immunogenicity Fluzone® Vaccine Children Who Received 2 Doses 2005-2006 Fluzone Formulation .</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria : Previously enrol study GRC28 receive 2 vaccination assign lot . Considered good health basis report medical history historydirected physical evaluation . Available duration study . Parent/legal representative willing able provide inform consent . Parent/legal representative able attend schedule visit comply trial procedure . Parent/legal representative willing permit venipuncture purpose collect blood sample . Exclusion Criteria : Receipt vaccine within past 7 day ( subject may defer seven day pass . ) Reported allergy egg protein , chicken protein constituent vaccine . Ever receive influenza vaccine , Visits 1 2 study GRC28 , know ever diagnose laboratoryconfirmed influenza . An acute illness fever ( rectal temperature ≥ 100.4°F [ 38.0°C ] ) 72 hour precede enrollment trial ( defer enrollment ) . Known bleed disorder . Participation interventional clinical trial within 30 day prior enrollment , plan participation another interventional clinical trial prior termination subject 's participation study . Known suspect impairment immunologic function receipt immunosuppressive therapy immunoglobulin since birth . Personal immediate family history congenital immune deficiency . Developmental delay , neurologic disorder , seizure disorder . Chronic medical , congenital , developmental disorder , opinion investigator , could interfere trial conduct completion . Known Human Immunodeficiency Virus ( HIV ) positive mother Hepatitis B surface antigen ( HBsAg ) positive mother . Known HIV , Hepatitis B , Hepatitis C infection . Administration immune globulin blood product within last three month , injected oral corticosteroid immunomodulator therapy within six week study vaccine . Individuals taper dose schedule oral steroid last &lt; 7 day may include trial long receive one course within last two week prior enrollment . Prior personal history GuillainBarré syndrome . Any condition , opinion investigator , would pose health risk subject interfere evaluation vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>11 Months</minimum_age>
	<maximum_age>14 Months</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Fluzone®</keyword>
	<keyword>Influenza</keyword>
	<keyword>Influenza virus infection</keyword>
	<keyword>Influenza vaccine</keyword>
</DOC>